What's New on the FDA Drugs Site
May 15, 2015
- FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
- FDA Issues Letters to Doctors Who May Have Purchased Counterfeit or Unapproved Prescription Drugs
- From our perspective: The U.S. drug supply chain and patient safety
- Drug Trials Snapshot: Corlanor
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Orange Book (updated)
- National Drug Code Directory
New and Generic Drug Approvals
May 14, 2015
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Bactroban | mupirocin calcium | Ointment;Nasal | Glaxosmithkline | Labeling Revision |
| Escitalopram Oxalate | escitalopram oxalate | Tablet; Oral | Mylan Pharma | Approval |
| Famvir | famciclovir | Tablet;Oral | Novartis | Manufacturing Change or Addition |
| Gilenya | fingolimod | Capsule;Oral | Novartis | Supplement |
| Isovue-128 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-200 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-250 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-300 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-370 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-M 200 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Isovue-M 300 | iopamidol | Injectable;Injection | Bracco | Manufacturing Change or Addition |
| Lamivudine; Zidovudine | lamivudine; zidovudine | Tablet; Oral Suspension | Mylan Labs | Manufacturing Change or Addition |
| Paricalcitol | paricalcitol | Solution;Intravenous | Hospira Inc | Manufacturing Change or Addition |
| Rufinamide | rufinamide | Tablet;Oral | Glenmark Generics | Tentative Approval |
| Sirturo | bedaquiline fumarate | Tablet;Oral | Janssen Therap | Labeling Revision |
| Treximet | naproxen sodium; sumatriptan succinate | Tablet;Oral | Pernix Ireland Ltd | Efficacy Supplement with Clinical Data to Support |
| Treximet | naproxen sodium; sumatriptan succinate | Tablet;Oral | Pernix Ireland Ltd | Labeling Revision |

Belum ada tanggapan untuk "CDER New May 18, 2015"
Post a Comment